Skip to main content
. 2022 Oct 27;21(12):2998–3006. doi: 10.1021/acs.jproteome.2c00544

Figure 6.

Figure 6

Expression and performance of the novel hub protein cysteine–cysteine motif chemokine ligand 20 (CCL20). (A) Validation of late pregnancy maternal plasma CCL20 levels. (B) Validation of early pregnancy maternal plasma CCL20 levels. (C) Receiver operating characteristic (ROC) curve of CCL20 in the late pregnancy maternal plasma. (D) ROC curve of CCL20 in the early pregnancy maternal plasma. (E) Comparison of the maternal plasma CCL20 expression in the early and late pregnancy of the control group. (F) Comparison of the maternal plasma CCL20 expression in the early and late pregnancy of the PE group. *P < 0.05, **P < 0.01, and ***P < 0.001.